Ankle-Foot Orthosis in Duchenne Muscular Dystrophy: A 4 year Experience in a Multidisciplinary Neuromuscular Disorders Clinic

被引:4
|
作者
Gupta, Anupam [1 ]
Nalini, Atchayaram [2 ]
Arya, Shanti Prakash [1 ]
Vengalil, Seena [2 ]
Khanna, Meeka [1 ]
Krishnan, Rashmi [1 ]
Taly, Arun B. [1 ,2 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Neurol Rehabil, Bengaluru 560029, Karnataka, India
[2] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bengaluru, India
来源
INDIAN JOURNAL OF PEDIATRICS | 2017年 / 84卷 / 03期
关键词
Duchenne muscular dystrophy; Ankle-foot-orthosis; Locomotion; DEPENDENT PROBE AMPLIFICATION; 6-MINUTE WALK TEST; NATURAL-HISTORY; DIAGNOSIS; CHILDREN; DEFORMITIES; MANAGEMENT; SURGERY; BOYS;
D O I
10.1007/s12098-016-2251-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To assess Ankle-Foot-Orthosis (AFO) requirement and ambulation in Duchenne Muscular Dystrophy (DMD) patients seen over a period of 4 y at a multi-disciplinary Neuromuscular disorders clinic (NMD). Methods A study was conducted in university quaternary research hospital with DMD patients confirmed by MLPA (multiplex ligation - dependent probe amplification) method and were evaluated between January 2012 and December 2015. Their ambulatory status, detailed neurological and functional status were recorded. Requirement of AFOs was determined and provided. Results In total 126 DMD children reported to the NMD clinic. Mean age at presentationwas 7.6 y (range 2 to 12 y, SD 2.1). Mean duration of illness at first evaluation was 3.4 y (range 0.5 to 10 y, SD 2.0). AFO's were advised at a mean age of 8.5 y (range 7 to 12 y, SD 1.8). Fifty-nine patients were advised AFO as resting or walking splint. At last follow-up 113 patients were still ambulatory whereas 13 had become wheel chair bound. Out of 59 patients, 48 were still wearing AFOs and the remaining discontinued AFOs for various reasons. Conclusions Children with DMD require wearing of AFOs as resting or walking splint, mostly in first or early second decade of life. As there is some gap between onset of clinical signs and requirement of orthosis, follow-up preferably at a multidisciplinary clinic at regular intervals is desirable for timely intervention in the form of AFOs or other splints to prolong ambulatory status in these patients.
引用
收藏
页码:211 / 215
页数:5
相关论文
共 50 条
  • [41] Using a novel ambulatory Ankle Foot Orthoses and Footwear Combination (NAFOFC) in Duchenne Muscular Dystrophy (DMD): Preliminary results for acceptability and changes in functional participation
    Bromwich, W.
    James, M.
    Stewart, C.
    Emery, N.
    Quinlivan, R.
    NEUROMUSCULAR DISORDERS, 2012, 22 (9-10) : 888 - 888
  • [42] Stiffness-Optimized Ankle-Foot Orthoses Improve Walking Energy Cost Compared to Conventional Orthoses in Neuromuscular Disorders: A Prospective Uncontrolled Intervention Study
    Waterval, Niels F. J.
    Brehm, Merel-Anne
    Altmann, Viola C.
    Koopman, Fieke S.
    Den Boer, Jasper J.
    Harlaar, Jaap
    Nollet, Frans
    IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING, 2020, 28 (10) : 2296 - 2304
  • [43] Multidisciplinary clinic for functional movement disorders (FMD): 1-year experience from a single centre
    Jacob, Alexandra E.
    Smith, Courtney A.
    Jablonski, Megan E.
    Roach, Abbey R.
    Paper, Kathy M.
    Kaelin, Darryl L.
    Stretz-Thurmond, Diane
    LaFaver, Kathrin
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (09): : 1011 - 1012
  • [44] Use of Complementary and Alternative Medicine in Children with Neuromuscular Disorders Followed at Penn State Health Pediatric Muscular Dystrophy Association Care Center Clinic
    Mittal, Rea
    Maltese, Caroline
    Bolt, Elizabeth
    Paul, Dustin
    Mainali, Gayatra
    Naik, Sunil
    Paudel, Sita
    Lehman, Erik
    Kumar, Ashutosh
    JOURNAL OF CHILD NEUROLOGY, 2023, : 367 - 372
  • [45] INCREASED EXPRESSION OF HLA ABC CLASS-I ANTIGENS BY MUSCLE-FIBERS IN DUCHENNE MUSCULAR-DYSTROPHY, INFLAMMATORY MYOPATHY, AND OTHER NEUROMUSCULAR DISORDERS
    APPLEYARD, ST
    DUBOWITZ, V
    DUNN, MJ
    ROSE, ML
    LANCET, 1985, 1 (8425): : 361 - 363
  • [46] Combination of steroids and ischial weight-bearing knee ankle foot orthoses in Duchenne's muscular dystrophy prolongs ambulation past 20 years of age - A case report
    Pardo, Andrea C.
    Do, Twee
    Ryder, Ted
    Meyer, Amy
    Miles, Lili
    Wong, Brenda L.
    NEUROMUSCULAR DISORDERS, 2011, 21 (11) : 800 - 802
  • [47] Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience
    Kokkinou, Eleftheria
    Roka, Kleoniki
    Alexopoulos, Alexis
    Tsina, Efthymia
    Nikas, Ioannis
    Krallis, Panagiotis
    Thanopoulou, Ioanna
    Nasi, Lambrini
    Makrygianni, Evanthia
    Tsoutsou, Eirini
    Kosma, Konstantina
    Tsipi, Maria
    Tzetis, Maria
    Frysira, Helen
    Kattamis, Antonis
    Pons, Roser
    POSTGRADUATE MEDICINE, 2019, 131 (07) : 445 - 452
  • [48] MoveDMD: phase 2 trial of edasalonexent, an NF-κB inhibitor, in 4 to 7-year old patients with Duchenne muscular dystrophy
    Finkel, R.
    Vandenborne, K.
    Sweeney, H.
    Finanger, E.
    Tennekoon, G.
    Shieh, P.
    Willcocks, R.
    Forbes, S.
    Triplett, W.
    Yum, S.
    Mancini, M.
    Friedman, M.
    Fretzen, A.
    Donovan, J.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S215 - S215
  • [49] Assessing the ability of boys with Duchenne muscular dystrophy age 4-7 years to swallow softgel capsules: Clinical trial experience with edasalonexent
    Mancini, Maria
    Shafai, Gigi
    Thaler, Elizabeth
    Donovan, Joanne M.
    Finkel, Richard S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (01) : 33 - 37
  • [50] Duchenne Muscular Dystrophy in a 4-Year-Old Girl due to Heterozygous Frame Shift Deletion of the Dystrophin Gene and Skewed X-Inactivation
    Schaenzer, A.
    Rau, I.
    Kress, W.
    Koehler, A.
    Neubauer, B.
    Hahn, A.
    KLINISCHE PADIATRIE, 2012, 224 (04): : 256 - 258